TARCEVA (erlotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
GENENTECH
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
XALKORI (crizotinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER ·+3
Parke-Davis Pfizer
GILOTRIF (afatinib dimaleate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · EPIDERMAL GROWTH FACTOR RECEPTOR POSITIVE NON-SMALL CELL LUNG CANCER ·+1
Boehringer Ingelheim
ZYKADIA (ceritinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
Novartis Pharmaceuticals
TAGRISSO (osimertinib mesylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · EGFR T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER ·+2
AstraZeneca Pharmaceuticals
ALECENSA (alectinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
GENENTECH
ALUNBRIG (brigatinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
MILLENNIUM PHAR
ALUNBRIG (brigatinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
MILLENNIUM PHAR
VIZIMPRO (dacomitinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR EXON 21 L858R SUBSTITUTION MUTATION ·+1
Parke-Davis Pfizer
LORBRENA (lorlatinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
Parke-Davis Pfizer
ERLOTINIB (erlotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
SUN PHARMACEUTI
ERLOTINIB (erlotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
TEVA USA
ERLOTINIB (erlotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
BRECKENRIDGE
ERLOTINIB (erlotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
MYLAN INSTITUTI
ERLOTINIB (erlotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
ARMAS PHARMACEU
ZYKADIA (ceritinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
Novartis Pharmaceuticals
TABRECTA (capmatinib hydrochloride)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) EXON 14 SKIPPING
Novartis Pharmaceuticals
BRAFTOVI (encorafenib)
ORAL TREATMENTS FOR NON-SMALL CELL LUNG CANCER · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+3
ARRAY/PFIZER
LUMAKRAS (sotorasib)
ORAL TREATMENTS FOR NON-SMALL CELL LUNG CANCER · NON-SMALL CELL LUNG CANCER WITH KRAS G12C MUTATION ·+1
AMGEN
KRAZATI (adagrasib)
ORAL TREATMENTS FOR NON-SMALL CELL LUNG CANCER · NON-SMALL CELL LUNG CANCER WITH KRAS G12C MUTATION
MIRATI THERAPEU
XALKORI (crizotinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER ·+3
Laboratories Div
AUGTYRO (repotrectinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ROS1 POSITIVE NON-SMALL CELL LUNG CANCER ·+1
BMS PRIMARYCARE
GAVRETO (pralsetinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · RET FUSION-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER ·+1
RIGEL PHARMACEU
ERLOTINIB HCL
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
CAMBER PHARMACE
ERLOTINIB HCL
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2
MYLAN INSTITUTI